Session 1201: Novel Molecular Therapies

Cochair(s): J Gluckman, J Cibelli
Date: Tue 12 February 2002, Time: 08:30 - 10:30
Location: CIS Auditorium

Oral Presentations

Time Number Title / Authors / Affiliations
08:30 489 Farnesyltransferase inhibitors
J Gibbs, C Buser, J
Department of Cancer Research and Medicinal Chemistry, Merck Research Laboratories, West Point, PA [ok]
08:45 490 Telomerase as a target for anticancer therapy
JW Shay
University of Texas Southwestern Medical Center Dallas, Email:
09:00 491 Antiangiogenesis
A Albini, F Tosetti, U Pfeffer, D Bisacchi, N Ferrari
Laboratory of Molecular Biology, Department of Health Sciences, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
09:30 492 Novel actions of inhibitors of dna topoisomerase i
WT Beck, Y Mo, PL Rachel, R Patel
1Department of Molecular Genetics1 and Pharmaceutics and Pharmacodynamics, 2The University of Illinois at Chicago, Chicago, IL USA
09:15 493 Differentiation therapy of human leukemia
L Degos
Institut Universitaire dHématologie, Hopital St Louis, AP-HP - Paris - France